Long and Short-term Metformin Consumption as a Potential Therapy to Prevent Complications of COVID-19
CONCLUSION: In this trial, metformin consumption had no effect on mortality and ICU admission rates in non-diabetic patients. However, metformin improved COVID-19 complications in diabetic patients who had been receiving metformin prior to COVID-19 infection, and it significantly lowered the intubation rates.PMID:37646067 | PMC:PMC10460805 | DOI:10.34172/apb.2023.066
Source: Adv Data - Category: Epidemiology Authors: Elnaz Shaseb Saba Ghaffary Alireza Garjani Elnaz Zoghi Nasrin Maleki Dizaji Somaieh Soltani Parvin Sarbakhsh Mohammad Hossein Somi Parya Valizadeh Ali Taghizadieh Masood Faghihdinevari Mojtaba Varshochi Behrooz Naghily Zhinous Bayatmakoo Parviz Saleh Sepe Source Type: research
More News: Aleve | Clinical Trials | COVID-19 | Diabetes | Endocrinology | Epidemiology | Fortamet | Metformin | Naproxen | Study